Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Kobayashi (Sapporo, Japan), K. Kuronuma (Sapporo, Japan), A. Saito (Sapporo, Japan), K. Ikeda (Sapporo, Japan), S. Ariki (Sapporo, Japan), M. Otsuka (Sapporo, Japan), H. Chiba (Sapporo, Japan), H. Takahashi (Sapporo, Japan). Insufficient serum L-ficolin is associated with the disease progression in pulmonary Mycobacterium avium complex disease. 2938

Member's Comments

No comment yet.

Related content which might interest you: Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005 Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Elevated serum adiponectin level in patients with mycobacterium avium-intracellulare complex pulmonary disease Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008 Combined chemotherapy in Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 657s Year: 2005 Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease Source: Eur Respir J, 58 (2) 1902269; 10.1183/13993003.02269-2019 Year: 2021 Factors related to response to intermittent treatment of mycobacterium avium complex lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 557s Year: 2006 A case of familial pulmonary Mycobacterium avium complex disease – experience in Japan Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course Source: Eur Respir J , 49 (3) 1600537; DOI: 10.1183/13993003.00537-2016 Year: 2017 Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016 Year: 2017 Long-term survival of patients with mycobacterium avium- intracellulare complex pulmonary disease (MAC-PD) Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Toll-like receptor polymorphisms associated with progression of Mycobacterium tuberculosis infection to pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 142s Year: 2006 Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA Source: Eur Respir J 2013; 42: 454-460 Year: 2013 Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease Source: Eur Respir J, 54 (1) 1900118; 10.1183/13993003.00118-2019 Year: 2019 Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection Source: Eur Respir J 2015; 46: 1823-1826 Year: 2015 Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria Year: 2018 Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis Source: ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020 Year: 2020 Susceptibility to nontuberculous mycobacterial lung disease Source: Eur Respir J 2008; 31: 1322-1333 Year: 2008